Latest News
-
Vedanta Reports 27% Decline in Q4 Net Profit Amid Tuticorin Impairment -
IndusInd Bank Q4 Results: PAT Soars 15% To Rs 2,349 Cr, NII Climbs 15%; 165% Dividend Declared -
Telecom Body COAI Advocates for Revenue Sharing with Traffic-Heavy Apps -
Tech Mahindra Q4 Results: Cons PAT Declines 41% YoY To Rs 661 Crore; Exits FY24 In Red -
1:5 Split Soon: Multibagger PSU Bank To Consider Dividend Too, Buy For TP Rs 650: Motilal Oswal -
Gold Price In US: Yellow Metal Rates Hold Steady Amidst Easing Middle East Tensions; GDP Data Awaited -
Multibagger Energy Stock To Reward Shareholders With 3 Bonus Shares, Hits 52-Week High -
Massive Rs 33/Sh Dividend By Larsen's IT Stock, 1650% Payout Soon; LTTS Earns Profit Of Rs 341 Crore In Q4 -
Rs 7.50/Share Dividend: Adani Group Cement Company Reports Strong Q4 Results; Profit Surges 2x YoY -
Closing Bell: Market Rebounds To End With Gains For 5th Straight Day; Sensex & Nifty Soar Led By Banks
Cipla To Acquire 100% Of Generic Businesses In US For $550M
Cipla, a global pharmaceutical company announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies.
The two companies are InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.
company share price details and financials
As per the agreement, the cash consideration payable for Invagen is USD 500 million and for Exelan is USD 50 million.
The above acquisitions will strengthen the overall presence of Cipla in the US in terms of scale, revenue, manufacturing opportunities and building a wide range of product portfolio.
The transaction is expected to be completed by end of December 2015, subject to completion of certain conditions precedent and receipt of applicable regulatory approvals including the expiration or termination of the waiting period provided for by the Hart-Scott-Rodino Antitrust Improvements Act, the company said in the press release.
The company stocks gave up morning gains and was een trading lower by 0.58 per cent on BSE at 12.50 pm IST. It touched an intraday high of Rs 679 and low of Rs 651 during the trade.
GoodReturns.in
